Sertraline use in mitochondrial cytopathy-associated depression: A case report
Dusunen Adam:The Journal of Psychiatry and Neurological Sciences · 12.06.2026 · 156-158
DOI: 10.14744/dajpns.2026.00329 ↗Kurz gefasst
Leserbrief in der Zeitschrift Dusunen Adam:The Journal of Psychiatry and Neurological Sciences, erschienen am 12.06.2026. Verfasst von Mehri Durak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gulhane Training and Research Hospital, Department of Child and Adolescent Psychiatry, Ankara, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Gulhane Training and Research Hospital, Department of Child and Adolescent Psychiatry, Ankara, Turkiye.
Zitieren
APA
Durak, M., & Ates, B. O. (2026). Sertraline use in mitochondrial cytopathy-associated depression: A case report. Dusunen Adam:The Journal of Psychiatry and Neurological Sciences, 156-158. https://doi.org/10.14744/dajpns.2026.00329
Vancouver
Durak M, Ates BO. Sertraline use in mitochondrial cytopathy-associated depression: A case report. Dusunen Adam:The Journal of Psychiatry and Neurological Sciences. 2026:156-158. doi:10.14744/dajpns.2026.00329
BibTeX
@article{Durak2026,
author = {Durak, Mehri and Ates, Burcin Ozlem},
title = {Sertraline use in mitochondrial cytopathy-associated depression: A case report},
journal = {Dusunen Adam:The Journal of Psychiatry and Neurological Sciences},
year = {2026},
pages = {156--158},
doi = {10.14744/dajpns.2026.00329}
}
EUVIMED